Presenter: Kelly McKenna (E-18)
Paper: Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Kim J, Hu C, El Achkar M, Black LE, Douville J, Larson A, Pendergast MK, Goldkind SF, Lee EA, Kuniholm A, Soucy A, Vaz J, Belur NR, Fredriksen K, Stojkovska I, Tsytsykova A, Armant M, DiDonato RL, Choi J, Cornelisesen L, Pereira LM, Augustine EF, Genetti CA, Dies K, Barton B, Williams L, Goodlett BD, Riley BL, Pasternak A, Berry ER, Pflock KA, Chu S, Reed C, Tyndall K, Agrawal PB, Beggs AH, Grant PE, Urion DK, Snyder RO, Waisbren SE, Poduri A, Park PJ, Patterson A, Biffi A, Mazzuli JR, Bodamer O, Berde CB, and Yu TW. Patient Customized Oligonucleotide Therapy for a Rare Genetic Disease J. The New England Journal of Medicine. 09 Oct 2019. 381(17):1644-1652. doi: 10.1056/NEJMoa1813279.
Presenter: David Granadier (E-18)
Paper: Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory
Ribeiro M, Brigas H, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, Coelho JE, Marques-Morgado I, Valente CA, Omenetti S, Stockinger B, Waisman A, Manadas B, Lopes LV, Silva-Santos B, Ribot JC. Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory. Science Immunology. 11 Oct 2019. 4 (40); DOI: 10.1126/sciimmunol.aay5199